# Fabrice Barlesi

Source: https://onco.cc/people/fabrice-barlesi/  
OnCo record `fabrice-barlesi` (Person). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)"; commercial use needs a licence.

## TL;DR

Fabrice Barlesi runs Europe's largest cancer centre and is a leading lung cancer trialist.

## Summary

Fabrice Barlesi is Director General of Gustave Roussy and a thoracic oncologist, having previously led thoracic oncology in Marseille. His specialisms are thoracic oncology, immunotherapy, precision medicine and cancer centre leadership. He runs Europe's largest cancer centre and is a leading lung cancer trialist whose research covers immune checkpoint inhibitors and targeted therapy in non-small-cell lung cancer. He was the founding coordinator of several French national lung cancer trial programmes, and his Lancet paper on Biomarkers France reported a nationwide programme of routine molecular profiling for patients with advanced non-small-cell lung cancer. His Gustave Roussy profile and PubMed listing are linked.

## Fields

- Kind: Person
- Last checked: 2026-09-08
- Role: Director General, Gustave Roussy; thoracic oncologist
- Specialisms: Thoracic oncology; Immunotherapy; Precision medicine; Cancer centre leadership

## Sources

- Gustave Roussy: https://www.gustaveroussy.fr/
- PubMed: https://pubmed.ncbi.nlm.nih.gov/?term=Barlesi%20F%5BAuthor%5D%20lung

## Connected records

- cancers: [Non-small-cell lung cancer](https://onco.cc/cancers/nsclc/)
- technologies: [Immune checkpoint inhibitors](https://onco.cc/technologies/checkpoint-inhibitor/)
- institutions: [Gustave Roussy](https://onco.cc/institutions/gustave-roussy/)
- key papers: [KRYSTAL-12 plain language summary: adagrasib for non-small-cell lung cancer with KRAS G12C mutations](https://onco.cc/key-papers/paper-krystal-12-plain-language-summary-future-oncol-2026/)
- companies: [Intergroupe Francophone de Cancérologie Thoracique](https://onco.cc/companies/ifct/)

---
JSON: https://onco.cc/api/v1/entities/fabrice-barlesi.json